Buccal absorption of etomidate from a solid formulation in dogs

Anesthesia and Analgesia

Volumn 86, Issue 5, 1998, Pages 1116-1122

  Zhang, Jie ^a   Maland, Lynn ^b   Hague, Brian ^b   Niu, Suyi ^a   Robertson, Scott ^b   Coleman, Dennis ^b   Stanley, Théodore H ^a   Streisand, James B ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b Anesta Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; SORBITOL;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; BUCCAL DRUG ADMINISTRATION; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; INTRAVENOUS DRUG ADMINISTRATION; MOUTH CAVITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEDATION;

ABSORPTION; ANESTHETICS, INTRAVENOUS; ANIMALS; BIOLOGICAL AVAILABILITY; CHEEK; DOGS; ETOMIDATE; MOUTH MUCOSA; PERMEABILITY;

EID: 0031960484     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199805000-00040     Document Type: Article

References (18)

1. Harris D, Robinson J. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sei 1992;81:1-10.
2. Stanley TH, Hague B, inventors. Methods and compositions for non-invasive administration of sedatives, analgesics and anesthetics. US patent 4 671 853. June 9, 1987.
3. Geise JL, Stanley TH. Etomidate: a new intravenous anesthetic induction agent. Pharmacotherapy 1983;3:251-8.
4. Geise JL, Stockham RJ, Stanley TH, et al. Etomidate versus thiopental for induction of anesthesia. Anesth Analg 1985;64: 871-6.
5. Ebert CD, John VA, Beall PT, Rosenzweig KA. Transbuccal absorption of diclofenac sodium in a dog model. In: Lee PI, Good VVR, eds. Controlled release technology. ACS Symposium Series, 1987:348.
6. Van Hamme MJ, Ghoneim MM, Ambre JJ. Pharmacokinetics of etomidate, a new intravenous anesthetic. Anesthesiology 1978; 49:274-7.
7. Avram MJ, Fragen RJ, Linde HW. High-performance liquid Chromatographie assay for etomidate in human plasma: results of preliminary clinical studies using etomidate for hypnosis in total intravenous anesthesia. J Pharm Sei 1983;72:1424-6.
8. Shaw J, Kay B, Keegan M, et al. Quantitative estimation of etomidate in water, plasma and blood: a comparison between high performance liquid chromatography and gas chromatography. J Pharmacol Methods 1982;7:311-9.
9. LeMoing JP, Levron JC. High-performance liquid Chromatographie determination of etomidate in plasma. J Chromatogr 1990 29:217-22.
10. Luhmann I, Szathmary SC. Sensitive and automated gas chromatographic method for the determination of etomidate in plasma samples. J Chromatogr 1990 32:150-4.
11. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982.
12. Verotta D. An inequality-constrained least-square deconvolution method. J Pharmacokinet Biopharm 1989;17:269-89.
13. Vaughan DP, Dennis M. Mathematical basis of point-area deconvolution method for determining m vivo input functions. J Pharm Sei 1978;67:663-5.
14. Flynn GL, Yalkowsky SH, Roseman TJ. Mass transport phenomena and models: theoretical concepts. J Pharm Sei 1974;63: 479-510.
15. Barsuhn CL, Olanoff LS, Gleason DD, et al. Human buccal absorption of flurbiprofen. Clin Pharmacol Ther 1988;44:225-31.
16. Deleted in proof.
17. Schuttler H, Schwieden H, Stoecicel H. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example. Eur J Anesthesiology 1985;2:133-42.
18. Jaarsma R, Gay M, Maland L, et al. Oral transmucosal etomidate in human volunteers [abstract]. Anesth Analg 1995;80:S208.